Table 4.
Invitro antimicrobial activity of different extracts of G. wallichianum.
| Strain | MIC (µg/mL)* | ||||
|---|---|---|---|---|---|
| ME | ET | EA | PE | CIP/AMF-B | |
| E. coli (MTCC 443) | 100 | 50 | 100 | 100 | 0.625 |
| M. luteus (10240) | 6.25 | 3.12 | 3.12 | 1.56 | 1.25 |
| K. pneumoniae (MTCC 19) | 6.25 | 25 | 25 | 25 | 0.039 |
| S. pneumoniae (MTCC 655) | 25 | 25 | 12.5 | 12.5 | 0.625 |
| H. influenzae (MTCC 3826) | 25 | 25 | 6.25 | 25 | 1.25 |
| N. mucosa (MTCC 1772) | 25 | 25 | 25 | 25 | 03.12 |
| C. albicans (ATCC 24433) | 200 | 6.25 | > 400 | > 400 | 1.25 |
| C. glabrata (ATCC2001) | > 400 | > 400 | > 400 | > 400 | 2 .5 |
| C. Paropsilosis (ATCCC90018) | > 400 | > 400 | > 400 | > 400 | 2 .5 |
*Results are the average of the triplicate readings. Where CIP: Ciprofloxacin (Positive antibacterial agent), AMF-B: Amphotericin-B (Positive antifungal agent), PE: Petroleum Ether, ET: Ethanol, ME: Methanol, EA: Ethyl Acetate.